Cargando…
Ghrelin Serum Concentrations Are Associated with Treatment Response During Lithium Augmentation of Antidepressants
BACKGROUND: Lithium augmentation of antidepressants is an effective strategy in treatment-resistant depression. The proteohormone ghrelin is thought to be involved in the pathophysiology of depression. The purpose of this study was to investigate the association of treatment response with the course...
Autores principales: | Ricken, Roland, Bopp, Sandra, Schlattmann, Peter, Himmerich, Hubertus, Bschor, Tom, Richter, Christoph, Elstner, Samuel, Stamm, Thomas J, Schulz-Ratei, Brigitte, Lingesleben, Alexandra, Reischies, Friedel M, Sterzer, Philipp, Borgwardt, Stefan, Bauer, Michael, Heinz, Andreas, Hellweg, Rainer, Lang, Undine E, Adli, Mazda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581484/ https://www.ncbi.nlm.nih.gov/pubmed/28911006 http://dx.doi.org/10.1093/ijnp/pyw082 |
Ejemplares similares
-
A GWAS top hit for circulating leptin is associated with weight gain but not with leptin protein levels in lithium-augmented patients with major depression
por: Bopp, Sandra K, et al.
Publicado: (2021) -
Impact of Lithium Treatment on FGF-23 Serum Concentrations in Depressive Patients
por: Fakhri, Hajar, et al.
Publicado: (2014) -
Stability of lithium treatment in bipolar disorder - long-term follow-up of 346 patients
por: Berghöfer, Anne, et al.
Publicado: (2013) -
The Antidepressant-like Effects of Estrogen-mediated Ghrelin
por: Wang, Pu, et al.
Publicado: (2015) -
Lithium Treatment Over the Lifespan in Bipolar Disorders
por: Volkmann, Constantin, et al.
Publicado: (2020)